Estrella Immunopharma, Inc. (ESLA)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$0.5352+$0.2173 (+68.35%) on the dayAs of the close; data may be delayed.
ESLA price, last 12 months
Key stats
- Previous close
- $0.3179
- Open
- $0.3100
- Day range
- $0.3020 – $0.8500
- 52-week range
- $0.2950 – $3.15
- Volume
- 63.1M
- Avg volume (20 days)
- 4.2M
- Market cap
- $17.8M
Performance
1W+11.2%
1M−13.3%
3M−44.7%
6M−75.7%
YTD−70.8%
1Y−73.0%
vs S&P 500, 1Y−88.9 pts
Technicals and fundamentals
About Estrella Immunopharma, Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $17.8M